Download Biochemistry Objectives 49

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

Jehovah's Witnesses and blood transfusions wikipedia , lookup

Blood type wikipedia , lookup

Hemorheology wikipedia , lookup

Men who have sex with men blood donor controversy wikipedia , lookup

Blood bank wikipedia , lookup

Transcript
Biochemistry Objectives 49
1.
Etiologies of six CAH steroidogenesis cases:
a.
StAR deficiency: causes sexual infantilism and salt loss due to the inability
to produce any steroid hormones
b.
3OH-SD (5,4-isomerase): causes mild virilism (due to DHEA shunt)
and salt loss due to the inability to produce DOC or aldosterone
c.
21-hydroxylase: causes virilism (due to testosterone shunt) and salt loss
due to the inability to produce DOC or aldosterone
d.
11-hydroxylase: causes virilism and hypertension due to high levels of
DOC without aldosterone
e.
18-hydroxylase: causes an initial salt loss followed by hypertension due to
increased DOC and testosterone
f.
17-hydroxylase: causes hypertension but no salt loss due to the cortisol
pathway production of DOC.
2.
Aldosterone action on Na+ retention and K+ secretion: aldosterone induces
DGK to open apical renal distal convoluted tubule Na+ channels (permease
hypothesis), increases basolateral Na+/K+ pumps (Na+ pump hypothesis), and
increases mitochondrial activity to increase Na+/K+ pump use (metabolic
hypothesis).
3.
Renin and ACE in angiotensin II formation: renin catalyzes the conversion of
angiotensinogen to angiotensin I, while ACE converts angiotensin I to angiotensin
II
Degradation of angiotensin II via angiotensin III: angiotensin II is converted
to angiotensin III via aminopeptidase, and angiotensin III is broken down by
angiotensinases to make inactive products
4.
Aldosterone mechanisms in:
a.
Autosomal recessive type I pseudohypoaldosteronism: mutation in the
downstream protein signaling after aldosterone binds MR
b.
Autosomal dominant type I pseudohypoaldosteronism: mutation in the
mineralocorticoid receptor causing an inability to bind aldosterone
c.
Conn’s syndrome (primary hyperaldosteronism): small adenoma in the
adrenal zona glomerulosa causing an increase in aldosterone
d.
Liddle syndrome (inherited pseudohyperaldosteronism): mutation in the
epithelial Na+ channel causing an increase of sodium mimicking the effect
of aldosterone
e.
Licorice consumption (acquired pseudohyperaldosteronism): licorice
consumption blocks 11-hydroxysteroid dehydrogenase, thus blocking
cortisol degradation. Cortisol can then act as aldosterone (since it binds to
the aldosterone receptor efficiently) and increases Na+ reabsorption.
5.
Control of ANP secretion: ANP secretion is controlled by 1 (excitatory) and 1
(inhibitory) adrenergic receptor binding to catecholamines
ANP action in the CNS: ANP decreases drinking and salt appetites, is a
vasodilator, and decreases aldosterone release
Action as an emergency hormone to counteract high salt intake: high salt
take increases blood pressure, and expands the atrial walls. ANP is released to
lower blood pressure, and acts as an emergency hormone to bring blood pressure
back to normal.
6.
Blood pressure lowering:
a.
Captopril: an ACE inhibitor; blocks conversion of Ang I to Ang II
b.
Sartans: blocks Ang II receptors so that Ang II loses its vasoconstrictive
property
c.
Spironolactone: aldosterone receptor antagonist causes decreased Na+
reabsorption to lower blood pressure in the face of high hormone levels
d.
ANP: opposes angiotensin, and increases aldosterone release while
lowering renin levels
7.
Biosynthesis of aldosterone and the effects of:
a.
Angiotensin II: angiotensin II upregulates aldosterone to increase blood
pressure
b.
ANP: ANP downregulates aldosterone to decrease blood pressure